Benzyl 4-{[(3R)-1-ethylpiperidin-3-yl]methyl}piperazine-1-carboxylate → 1-{[(3R)-1-ethylpiperidin-3-yl]methyl}piperazine
반응식
[CH2:1]([N:3]1[CH2:8][CH2:7][CH2:6][C@@H:5]([CH2:9][N:10]2[CH2:15][CH2:14][N:13](C(OCC3C=CC=CC=3)=O)[CH2:12][CH2:11]2)[CH2:4]1)[CH3:2]>C(O)C.[Pd]>[CH2:1]([N:3]1[CH2:8][CH2:7][CH2:6][C@@H:5]([CH2:9][N:10]2[CH2:11][CH2:12][NH:13][CH2:14][CH2:15]2)[CH2:4]1)[CH3:2]참가 물질
4
실험 절차
Benzyl 4-{[(3R)-1-ethylpiperidin-3-yl]methyl}piperazine-1-carboxylate (352 mg) was dissolved in ethanol (50 ml). 10% Palladium on carbon (35 mg) was added and the mixture stirred for 18 hours at room temperature under an atmosphere of hydrogen. The reaction mixture was filtered through a pad of celite and the filtrate concentrated in vacuo to give the title compound (225 mg).
후처리
- filtrationThe reaction mixture was filtered through a pad of celite
- concentrationthe filtrate concentrated in vacuo
출처 및 근거
- ORD 기록
- ord-095f7f67f4844c068750d3bffb00e080
- 출처 데이터셋
- uspto-grants-2014_04
- 특허 번호
- US08710224B2
반응 노트
불러오는 중…